1. SALL4 is a useful marker for pediatric yolk sac tumors
- Author
-
Chen Wang, Baiping Sun, Shaoguang Feng, Peng Wu, Jingru Zhao, Ruogu Luo, Quan Xu, and Xiaoming Chen
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Glypican 3 ,03 medical and health sciences ,0302 clinical medicine ,Testicular Neoplasms ,SALL4 ,030225 pediatrics ,Biomarkers, Tumor ,medicine ,Humans ,Child ,Ovarian Neoplasms ,Lung ,business.industry ,Lymphoblastic lymphoma ,Endodermal Sinus Tumor ,Myeloid leukemia ,General Medicine ,medicine.disease ,Immunohistochemistry ,eye diseases ,Staining ,medicine.anatomical_structure ,Pediatrics, Perinatology and Child Health ,Biomarker (medicine) ,Female ,030211 gastroenterology & hepatology ,Surgery ,business ,Transcription Factors - Abstract
SALL4 is a zinc finger transcription factor that exerts its physiological role during embryo-fetal development. Analyses of SALL4 expression have shown its oncogenic role in precursor B-cell lymphoblastic lymphoma, acute and chronic myeloid leukemia, gastrointestinal, breast, and lung cancers. The aim of this study was to determine the immunohistochemical profile of SALL4 in pediatric yolk sac tumors (YSTs). Immunohistochemistry detection of SALL4 was performed in 22 cases of pediatric YSTs and 10 mature teratomas. The percentage of tumor cells stained was scored as 0, 1+ (1–30% cells), 2+ (31–60%), 3+ (61–90%), and 4+ (> 90%). To compare its sensitivity and specificity with Glypican-3 and α-fetoprotein (AFP), we also stained tumors from these cases for Glypican-3 and AFP. In contrast to AFP and glypican-3, SALL4 staining in more than 90% of the tumor cells was seen in all 22 pediatric YSTs (100% sensitivity) (P
- Published
- 2020
- Full Text
- View/download PDF